indirubin-3'-monoxime has been researched along with Arterial Occlusive Diseases in 1 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schwaiberger, AV | 1 |
| Heiss, EH | 1 |
| Cabaravdic, M | 1 |
| Oberan, T | 1 |
| Zaujec, J | 1 |
| Schachner, D | 1 |
| Uhrin, P | 1 |
| Atanasov, AG | 1 |
| Breuss, JM | 1 |
| Binder, BR | 1 |
| Dirsch, VM | 1 |
1 other study available for indirubin-3'-monoxime and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Indirubin-3'-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo.
Topics: Animals; Arterial Occlusive Diseases; Becaplermin; Cell Cycle; Cell Proliferation; Cells, Cultured; | 2010 |